Crystal structure of TIGIT in complexed with Tiragolumab
External Resource: Annotation
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
| C | | e8jeoC01 | A: ATPD N-terminal domain-like | X: N-terminal domain of the delta subunit of the F1F0-ATP synthase | H: Galactose-binding domain-like | T: GMC_oxred_C | F: | ECOD (20:10:01) |
| B | | e8jeoB01 | A: ATPD N-terminal domain-like | X: N-terminal domain of the delta subunit of the F1F0-ATP synthase | H: Galactose-binding domain-like | T: GMC_oxred_C | F: | ECOD (20:10:01) |
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|
| | Light Chain | IGKV4 | Kappa | t-cell immunoreceptor with ig and itim domains | SAbDab (2026-03-13) |
| | Heavy Chain | IGHV6 | - | t-cell immunoreceptor with ig and itim domains | SAbDab (2026-03-13) |
| Chain | Name | Target | Provenance Source |
|---|
| Tiragolumab | TIGIT/WUCAM/VSTM3 | Therapeutic SAbDab (2026-03-13) |
| Tiragolumab | TIGIT/WUCAM/VSTM3 | Therapeutic SAbDab (2026-03-13) |
| Chains | Polymer | Molecular Function | Biological Process | Cellular Component |
|---|
| antibody light chain | - | - | - |
| antibody heavy chain | - | - | - |
| T-cell immunoreceptor with Ig and ITIM domains | | | |
| Chains | Drug Target   | Associated Disease |
|---|
| Pharos:  Q495A1 | |